Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 005 - Dave Stevens – microbial therapeutics, pharmaceutical manufacturing, building a best-in-class contract development manufacturing organisation

Episode 005 - Dave Stevens – microbial therapeutics, pharmaceutical manufacturing, building a best-in-class contract development manufacturing organis…

FromInside Matters


Episode 005 - Dave Stevens – microbial therapeutics, pharmaceutical manufacturing, building a best-in-class contract development manufacturing organis…

FromInside Matters

ratings:
Length:
83 minutes
Released:
Nov 3, 2022
Format:
Podcast episode

Description

Learn more about the podcast here - https://insidematters.health/
David (Dave) Stevens is the CEO of Arranta Bio, a leading contract development manufacturing organisation that specialises in advanced therapies, including microbiome therapeutics. ArrantaBio supports many of the world's leading microbiome companies that develop and manufacture novel drugs for the benefit of patients around the world. 
Dave was formerly the Senior Vice President and Head of AMRI’s Drug Product business unit where he had P&L responsibility for sales and operations. During his tenure, he led the division through a period of significant growth and capacity expansion. Before leading the division, Dave held senior leadership roles at AMRI including Vice President, Sales & Marketing and General Manager of a sterile dosage form development and GMP manufacturing facility.
Dave is a native Scot that is passionate about building Scotland into a global leader in life sciences, as well as being a big believer in the power of the microbiome to benefit health. 
- 0:00 Intro
- 1:14: jet lag, training, intermittent fasting
- 3:40 what motivates you to work
- 5:00 moving from startup to scale up
- 5:30 challenges in microbiome manufacturing / microbial fermentation
- 5:58 what is a contract development manufacturing organisation (CDMO)?
- 7:00 challenges for the microbiome field
- 7:30 the microbiome as a therapeutic target
- 09:40 intermittent fasting
- 10:33 health span and lifespan
- 12:37 what does ArrantaBio do
- 14:00 mRNA technology - overcoming challenges and realising promises
- 17:35 a Scottish success story
- 21:18 mindset in Scotland vs USA
- 27:15 how to become life sciences capital of the world
- 32:27 first approved microbiome therapies
- 35:12 characterisation of the microbial ecosystems
- 37:20 dogs and depression
- 38:10 types of microbiome therapies
- 42:36 competing with other CDMOs
- 46:02 manufacturing probiotics
- 47:10 Good manufacturing practice
- 48:50 Probiotics
- 50:41 lost the screen
- 51:50 innovation in the microbiome field
- 53:00 lyophilisation
- 54:24 Fermentation systems
- 55:25 EnteroBiotix
- 57:00 the gut-brain axis
- 58:35 how good gut health makes you feel
- 1:00:02 Gene therapy and the costs of cures
- 1:03:00 the start of ArrantaBio and vision for the future
- 1:08:00 buying the best to be the best
- 1:10:30 leading organisations
- 1:11:20 being a leader
- 1:15:10 spending time with the best to be the best
- 1:17:30 being a vision and mission-driven company
- 1:17:45 the future of ArrantaBio
 
 
Released:
Nov 3, 2022
Format:
Podcast episode

Titles in the series (44)

The gut health show – conversations with the most forward-thinking minds in health, fitness, science, nutrition and business. In-depth discussions about how our gut microbiome impacts our health, well-being, mood and more. Inside Matters was conceived by microbiome expert Dr James McIlroy as a platform to raise awareness of the importance of the gut microbiome. Our aim is to inspire and educate listeners around the world about the importance of gut health, equipping them with the knowledge they need to transform their lives for the better.